Stephanie Manson Brown

Stephanie Manson Brown currently serves as the Head of Clinical Development & Scientific Innovation and Skincare R&D at AbbVie since May 2019, and also holds the position of Vice President, Global Therapeutic Area Head Clinical Development for Aesthetics. Additionally, since May 2020, Manson Brown has been the Vice President and Head of Clinical Development & Scientific Innovation at Allergan Aesthetics. Prior experience includes roles at Allergan from February 2014 to May 2019, where responsibilities encompassed Global Therapeutic Area Head Clinical Development and Global Head of Medical Affairs for Aesthetics and Medical Dermatology. Earlier positions at Pfizer featured roles such as Medical Affairs Team Lead Customer Marketing UK and Medical Adviser. Manson Brown began a medical career at Novo Nordisk A/S as a Medical Advisor from April 2008 to August 2010. Educational qualifications include an MFPM in Pharmaceutical Medicine from the Faculty of Pharmaceutical Medicine, MRCS in Surgery from the Royal College of Surgeons (Edin), and an MBBS in Medicine from the University of Newcastle.